Author

A. M. Jackson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3 Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Assay:proteomics· 4 Research Focus:host-pathogen & immune response· 3 Organism:human· 3 Research Focus:cell type annotation· 2 Organism:virus· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1

Frequent Co-Authors

A. B. Ward· 4 shared J. L. Torres· 2 shared A. Antanasijevic· 1 shared A. B. McDermott· 1 shared A. Chopde· 1 shared A. J. Rodriguez· 1 shared A. Maleka· 1 shared A. Torrents de la Pena· 1 shared

Activity by Year

2019-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersImmunology

A. B. Ward

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Immune memory shapes human polyclonal antibody responses to H2N2 vaccination

Y. R. Yang, J. Han, H. R. Perrett, S. T. Richey, A. M. Jackson, A. J. Rodriguez, R. A. Gillespie, S. O'Connell, J. E. Raab, L. Y. Cominsky, A. Chopde, M. Kanekiyo, K. V. Houser, G. L. Chen, A. B. McDermott, , A. B. Ward

This study examines how prior H2 influenza exposure influences polyclonal antibody responses to H2N2 vaccination, showing differences in epitope targeting between H2-exposed and H2-naive individuals.

bioRxiv · Aug 23, 2023Immunology

Structural mapping of antibody landscapes to human betacoronavirus spike proteins

S. Bangaru, A. Antanasijevic, N. Kose, L. M. Sewall, A. M. Jackson, N. Suryadevara, X. Zhan, J. L. Torres, J. Copps, A. Torrents de la Pena, J. E. Crowe, A. B. Ward

The paper maps epitopes of polyclonal antibodies against beta-coronavirus spike proteins in human sera, revealing cross-reactive patterns between seasonal and SARS-2 infections.

bioRxiv · Sep 30, 2021Immunology

One dose of COVID-19 nanoparticle vaccine REVC-128 provides protection against SARS-CoV-2 challenge at two weeks post immunization

M. Gu, J. L. Torres, J. Greenhouse, S. Wallace, C.-I. Chiang, A. M. Jackson, M. Porto, S. Kar, Y. Li, A. B. Ward, Y. Wang

bioRxiv · Apr 2, 2021Microbiology

Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants

M. Yuan, D. Huang, C.-C. D. Lee, N. C. Wu, A. M. Jackson, X. Zhu, H. Liu, L. Peng, M. J. van Gils, R. W. Sanders, D. R. Burton, S. M. Reincke, H. Prüss, J. Kreye, D. Nemazee, , I. A. Wilson

The paper examines how mutations at E484 and K417 in SARS-CoV-2 variants affect neutralizing antibodies, showing reduced efficacy against certain antibody families but not others.

bioRxiv · Feb 16, 2021Microbiology

Primary human macrophages are polarized towards pro-inflammatory phenotypes in alginate hydrogels

D. Delcassian, A. Maleka, D. Opoku, V. Palomares Cabeza, C. Merry, A. M. Jackson

This study shows that 3D alginate hydrogels promote M2-like macrophage polarization with increased CD86 and IL1β expression, suggesting intrinsic effects on macrophage phenotypes.

bioRxiv · Nov 8, 2019 · PreprintImmunology